Cielo Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.6/10
Best for: flat-rate compounded GLP-1 at the lowest 3-month bundle prices
Cielo scores highest on the strength of its clinical program: drug options and dosing support.
Semaglutide
then $199/mo ongoing
Tirzepatide
then $299/mo ongoing
Price checked on Cielo’s site,
What the monthly price covers
Medication
Included
Provider visits
Not stated
Shipping
Included
Lab work
Not stated
Coaching
Not stated
No insurance needed · Vetted by our editors
Cielo is a compounded-GLP-1-only telehealth platform offering semaglutide and tirzepatide with no brand-name drugs and no TRT, hair, or mental-health add-ons, making it a focused, single-purpose alternative to multi-vertical providers. Pricing is flat at every dose, and clinical care is delivered through MD Integrations. Month to month it lists at $199 for semaglutide and $299 for tirzepatide, and longer plans bring that down to $84 and $119 a month on a 12-month plan.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money
Vetted alternatives to Cielo
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
CoreAge Rx
Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Editorial score · methodology
Cielo at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $199/mo (after intro offer) ($139 intro price)
- Pricing model
- Flat: dose increases don't raise the monthly price
- What's included
- Medication · Shipping
- FDA status
- No FDA warning letter on record
How we scored Cielo
Each dimension is scored algorithmically from Cielo’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
7.6/10At $199/mo (after intro offer), Cielo runs about 11% above the $179 median for GLP-1 providers (each program's lowest listed ongoing monthly price for compounded semaglutide), with an intro price of $139. Pricing is flat across doses, so there is no escalation markup as you titrate up.
Effectiveness25%
8.5/10Cielo offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.6/10Online intake and platform experience; 8 platform features disclosed.
Trust & Safety15%
7.7/10Core details confirmed by our editors; no FDA warning letters on file.
Accessibility10%
6.5/10Cielo's exact state footprint isn't published. Confirm coverage in your state before signing up.
Support10%
6.3/10Cielo provides standard clinician follow-up; no extended coaching or community program is disclosed.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Cielo review
Last checked November 2026- Confirmed current pricing across 4 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the provider's public sign-up flow, stopping before payment
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.
What we checked
- Provider's own pricing page
- $99–$299/mo across 4 dose/plan tiers (checked November 2026)
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with Cielo
We walked Cielo’s public signup flow in July 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Complete a secure online medical intake.
- 2A licensed physician reviews your health before treatment begins.
- 3If approved, the physician prescribes compounded GLP-1 medication.
- 4Medication arrives discreetly at your home within a few days.
- Pricing is prominent on the homepage before intake: compounded semaglutide from $115/month and compounded tirzepatide from $180/month on 3-month plans.
- Regular (non-discounted) prices shown as $199/month semaglutide and $299/month tirzepatide.
- Emphasizes physician-led care with time taken to understand health first.
- Medication described as shipping discreetly within a few days.
- Support reachable by phone and email.
Cielo customer support
- Phone
- (727) 607-7548
GLP-1 medications Cielo offers
Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
Flash-sale price $139 for the monthly plan (regularly $199/month). Longer plans: 6 months $89/mo, 12 months $84/mo, same price at any dose.
Flash-sale price $189 for the monthly plan (regularly $299/month). Longer plans: 6 months $129/mo, 12 months $119/mo, same price at any dose.
Ready to get started?
Plans and promotions change often, so check Cielo's current pricing and active discounts before you decide.
What we like
- Among the lowest long-plan prices in compounded GLP-1 ($84/mo semaglutide and $119/mo tirzepatide on a 12-month plan)
- Single flat price across all doses simplifies titration planning
- Corporate address (St. Petersburg, FL) and customer-service phone published
Watch-outs
- No LegitScript, NABP .pharmacy, or HIPAA badge on the home page
- Pharmacy partner not named (only 'regulated FDA pharmacy partners')
- State coverage list not published, so you can't confirm all-50-state availability
- Clinical care runs through MD Integrations, a shared third-party network used by many brands
- No brand-name Wegovy or Zepbound option
- Donation page shows 0% next to a 10%-pledge claim, an apparent discrepancy
Cielo: a stripped-down, price-first compounded GLP-1 platform
Cielo is one of the rare telehealth brands that does exactly one thing. There is no TRT upsell, no hair-loss bolt-on, no anxiety or sleep add-on, and no brand-name Wegovy or Zepbound. It sells compounded semaglutide and compounded tirzepatide and nothing else. If your only goal is to start a GLP-1 at the lowest plausible monthly cost and you don't need the program to be anything more than that, Cielo is squarely aimed at you. If you want hand-holding, brand-name medication, or visible third-party accreditation, you'll want to read the cautions below before you commit.
How the pricing works
Cielo's whole pitch is built on a flat-rate model: the same price applies at every dose, so your monthly cost doesn't climb as you titrate up. That's useful, because at many competitors the bill rises each time your clinician increases your dose. Here the math is fixed from the start.
On a three-month bundle, semaglutide is $99 a month, and the six- and 12-month plans go lower still. The bundle rate lands well below the category median of $179, which is why Cielo ranks as one of the lowest-priced compounded GLP-1 options around. Month to month it is $199 (after intro offer), cut to $139 during a limited-time flash sale, so the monthly plan still costs noticeably more for people who don't want to prepay a quarter up front. You're paying a premium for flexibility. Tirzepatide follows the same structure at a higher tier. Both prices include the medication and free expedited shipping, so the headline figure is closer to your true out-of-pocket than at providers who tack on separate shipping or visit fees.
How we get the market median: $179 is the middle value of each program's lowest listed ongoing monthly price for compounded semaglutide (month to month, not a first-month promo, a prepaid plan or a price with a membership on top), across the 121 programs that publish one.
- Lowest cost comes from the longer bundle; the month-to-month rate is meaningfully higher
- Same price at every dose, so titrating up the ladder never raises your bill
- Medication and expedited shipping included in the quoted price
- No brand-name option: compounded semaglutide and tirzepatide only
The medications, and how care is delivered
You're choosing between two compounded molecules: semaglutide (the compound behind Ozempic and Wegovy) and tirzepatide (the compound behind Mounjaro and Zepbound). Cielo doesn't offer the FDA-approved branded pens, and it doesn't pretend to. That keeps the price down but means you're relying on a compounding pharmacy rather than a manufacturer's sealed product.
Clinical care isn't delivered by Cielo itself. By its own terms, 'Cielo Health' is not a medical practice; care comes through MD Integrations, a third-party clinician network that many telehealth brands share. A licensed clinician reviews your intake and, if appropriate, writes the prescription. This is a common and legitimate structure, but the brand you're signing up with and the people making your medical decisions are separate organizations.
Focus and flat pricing
Two things make Cielo distinct. First, by refusing every adjacent product category, it can compete almost entirely on price and simplicity, and it does. Second, the flat-dose pricing removes the bill-creep that frustrates patients at dose-tiered providers. It's also more transparent about its corporate identity than many budget compounders, with a published St. Petersburg, Florida corporate address and a working customer-service phone line.
Where Cielo falls short
This is a lean operation, and the gaps show. There's no LegitScript certification, no NABP .pharmacy seal, and no HIPAA badge displayed on the site. Those are the trust signals you'd want to see on a platform handling prescriptions and health data. The compounding pharmacy is never named; you're told only that it uses 'regulated FDA pharmacy partners.' The list of states where Cielo operates isn't published anywhere on the site, so you can't confirm coverage in your state before signing up. There's also a small but telling inconsistency: a donation page shows zero percent next to a claimed ten-percent pledge. None of these is automatically disqualifying, but together they mean you're taking more on faith than at a fully documented provider. Compare OurView Health, which names its pharmacy, publishes its state list and charges the same at every dose, but it isn't available in four states.
Who should choose it, and who should skip it
Choose Cielo if you're a price-sensitive, self-directed patient who already knows you want compounded semaglutide or tirzepatide, is comfortable prepaying a multi-month bundle to hit the lowest rate, and doesn't need brand-name medication or a long list of accreditation badges to feel comfortable.
Skip it if you want the FDA-approved branded pens, if seeing a named pharmacy and visible certifications is non-negotiable for you, if you need to confirm state availability before paying, or if you want a more high-touch coaching relationship rather than a transactional fill-and-ship service. Readers who want a LegitScript seal they can check for themselves can look at StackMD, which carries one and names its legal entity and prescribing partner, but its prices climb with your dose and checkout adds a consultation fee.
The bottom line
Cielo is a no-frills, price-led entry into compounded GLP-1 therapy. The flat per-dose pricing and free shipping make the $99-a-month bundle one of the better headline deals in the category, and the focus on a single job is refreshing. But you're trading away transparency: an unnamed pharmacy, missing accreditation badges, and an undisclosed state list mean you should do your own diligence before handing over payment. For a budget-minded patient who knows exactly what they want, it's a reasonable pick. Go in with eyes open, and see our scoring methodology for how we weigh price against trust signals like these.
The Bottom Line
Cielo scores highest on the strength of its clinical program: drug options and dosing support.
Ready to start with Cielo?
From $199/mo (after intro offer). See current pricing and start your free consultation.
Cielo might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Head-to-head
Compare Cielo vs…
Cielo scores7.6/10
Side-by-side pricing, medications and scores. Pick a matchup.
Cielo vs Amazon One Medical
Amazon One Medical scores 8.5/10

Cielo vs Vytora Health
Vytora Health scores 8.4/10
Scores are our independent editorial ratings out of 10.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Cielo review:
Sources & methodology (as of November 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Cielo's current pricing
Plans from $199/mo (after intro offer). Start your free consultation to check eligibility and today's price.